Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D). | Bioorg Med Chem Lett | 2023 | 37778428 | PubTator, text mining | PubMed |
| NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis. | Sci Immunol | 2023 | 37774007 | PubTator, text mining | PubMed |
| The critical role of platelet in cancer progression and metastasis. | Eur J Med Res | 2023 | 37770941 | PubTator, text mining | PubMed |
| Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment. | Medicina (Kaunas) | 2023 | 37763731 | PubTator, text mining | PubMed |
| Indicators of HSV1 Infection, ECM-Receptor Interaction, and Chromatin Modulation in a Nuclear Family with Schizophrenia. | J Pers Med | 2023 | 37763159 | PubTator, text mining | PubMed |
| Harnessing Immune Response in Acute Myeloid Leukemia. | J Clin Med | 2023 | 37762763 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy. | World J Surg Oncol | 2023 | 37759234 | PubTator, text mining | PubMed |
| Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality. | Front Immunol | 2023 | 37753084 | PubTator, text mining | PubMed |
| Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we? | Cell Commun Signal | 2023 | 37749597 | PubTator, text mining | PubMed |
| Structural Variation Detection and Association Analysis of Whole-Genome-Sequence Data from 16,905 Alzheimer's Diseases Sequencing Project Subjects. | medRxiv | 2023 | 37745545 | PubTator, text mining | PubMed |
| IL-17a-producing γδT cells and NKG2D signaling mediate bacterial endotoxin-induced neonatal lung injury: implications for bronchopulmonary dysplasia. | Front Immunol | 2023 | 37744375 | PubTator, text mining | PubMed |
| NKG2D receptor regulates CD4+T cell differentiation via interaction with dendritic cells in patients with juvenile idiopathic arthritis. | Clin Immunol | 2023 | 37741520 | PubTator, text mining | PubMed |
| Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy. | Cell Rep Methods | 2023 | 37738982 | PubTator, text mining | PubMed |
| Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer. | Front Oncol | 2023 | 37711200 | PubTator, text mining | PubMed |
| The Three-Dimensional In Vitro Cell Culture Models in the Study of Oral Cancer Immune Microenvironment. | Cancers (Basel) | 2023 | 37686542 | PubTator, text mining | PubMed |
| Targeting NKG2DL with Bispecific NKG2D-CD16 and NKG2D-CD3 Fusion Proteins on Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37685962 | PubTator, text mining | PubMed |
| Electrolyte imbalance causes suppression of NK and T cell effector function in malignant ascites. | J Exp Clin Cancer Res | 2023 | 37684704 | PubTator, text mining | PubMed |
| Integrating genomics and proteomics data to identify candidate plasma biomarkers for lung cancer risk among European descendants. | Br J Cancer | 2023 | 37679517 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer. | J Cancer | 2023 | 37670965 | PubTator, text mining | PubMed |
| LncRNA TYMSOS facilitates breast cancer metastasis and immune escape through downregulating ULBP3. | iScience | 2023 | 37664624 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=15